Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001020365 | SCV001181836 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-05-22 | criteria provided, single submitter | clinical testing | The c.346-5C>T intronic variant results from a C to T substitution 5 nucleotides upstream from coding exon 5 in the RAD51D gene. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will not have any significant effect on splicing. Based on the available evidence, the clinical significance of this variant remains unclear. |
Labcorp Genetics |
RCV003528261 | SCV004245921 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 4 | 2024-04-15 | criteria provided, single submitter | clinical testing |